KAMAŞAK, T. Et Al. 2022. The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study. EPILEPSY RESEARCH , vol.184 .

KAMAŞAK, T., SERDAROĞLU, E., Yilmaz, O., Kilic, B. A., Polat, B. G., Erdogan, I., ... Sen, A. D. Y.(2022). The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study. EPILEPSY RESEARCH , vol.184.

KAMAŞAK, TÜLAY Et Al. "The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study," EPILEPSY RESEARCH , vol.184, 2022

KAMAŞAK, TÜLAY Et Al. "The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study." EPILEPSY RESEARCH , vol.184, 2022

KAMAŞAK, T. Et Al. (2022) . "The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study." EPILEPSY RESEARCH , vol.184.

@article{article, author={TÜLAY KAMAŞAK Et Al. }, title={The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study}, journal={EPILEPSY RESEARCH}, year=2022}